Key Insights

Highlights

Success Rate

90% trial completion (above average)

Published Results

19 trials with published results (7%)

Research Maturity

152 completed trials (58% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

6.2%

16 terminated out of 260 trials

Success Rate

90.5%

+3.9% vs benchmark

Late-Stage Pipeline

3%

8 trials in Phase 3/4

Results Transparency

13%

19 of 152 completed with results

Key Signals

19 with results90% success16 terminated

Data Visualizations

Phase Distribution

164Total
Not Applicable (88)
Early P 1 (5)
P 1 (27)
P 2 (36)
P 3 (1)
P 4 (7)

Trial Status

Completed152
Recruiting33
Unknown30
Terminated16
Not Yet Recruiting7
Active Not Recruiting7

Trial Success Rate

90.5%

Benchmark: 86.6%

Based on 152 completed trials

Clinical Trials (260)

Showing 20 of 20 trials
NCT05633706Active Not Recruiting

Evaluation of the SIMBA Capsule for Small Intestinal Dysbiosis

NCT07842848Completed

Clinical Presentation of Celiac Disease in Last 14 Years

NCT07832994Not ApplicableRecruitingPrimary

Metaboic Syndrome and Fatty Liver in Celiac Disease Females: Reponse to Exercise in Adolescents

NCT04031469Suspended

A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease

NCT07831408Not ApplicableNot Yet RecruitingPrimary

Study On The Efficacy Of Galactol In Patients With Celiac Disease And Functional Abdominal Disorders

NCT05636293Phase 2CompletedPrimary

Double Blind, Placebo-controlled Trial to Establish Safety and Efficacy of Ritlecitinib in Celiac Disease Patients in Remission

NCT06587828Completed

A Biospecimen Collection Study to Identify the Targets of Disease-Reactive T Cells in Patients With Autoimmune Disease

NCT07815821Not ApplicableCompletedPrimary

Effects of A2 Dairy Consumption in Celiac Adolescents

NCT05209568Not ApplicableEnrolling By InvitationPrimary

Immune Responses to Gluten

NCT06557772Phase 2Active Not Recruiting

A Phase 2a/b Study of the Efficacy and Safety of Subcutaneous Amlitelimab in Adults With Nonresponsive Celiac Disease

NCT06807463Phase 2Active Not RecruitingPrimary

A Trial to Assess the Efficacy and Safety of TEV-53408 in Adults With Celiac Disease

NCT07777666Not ApplicableNot Yet RecruitingPrimary

Effects of Kefir on Celiac Disease

NCT07239336Phase 2RecruitingPrimary

Study of DONQ52 in Active Celiac Disease

NCT06908057Active Not Recruiting

Accessing Care, Clinical Trials and Screening for Underserved Children and Adults With Type 1 Diabetes (ACCESS-T1D)

NCT07750535Recruiting

Liver Steatosis and Fibrosis in Non-Celiac Wheat Sensitivity Patients: a Prospective Study

NCT07750795Not ApplicableRecruitingPrimary

Nutrition and Physical Activity Education in Children With Celiac Disease

NCT07063823Phase 1CompletedPrimary

A First-in-human Study to Evaluate the Safety and Tolerability of HB-2121 as a Diagnostic for Celiac Disease

NCT07377565Phase 1RecruitingPrimary

A First-in-Patient Study to Evaluate the Safety and Tolerability of HB-2121 as a Diagnostic for Celiac Disease

NCT05680012Not ApplicableRecruitingPrimary

Tissue Destruction and Healing in Celiac Disease

NCT07701655Not Yet RecruitingPrimary

Personalized Approach to Celiac Disease Diagnosis

Scroll to load more

Research Network

Activity Timeline